Company / Total Debt
AbbVie Total Debt History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$64.5B
FY2025
5-year range
$59.2B / $76.0B
FY2021-FY2025
Trend
-3.5%
vs FY2024
Sector context
#1 of 86
Health Care
What the data says
Among 86 Health Care companies, AbbVie is in the bottom 1% for total debt. Total Debt has fluctuated over the past 7 years, ranging from $59.2B in FY2023 to $84.9B in FY2020.
Based on SEC 10-K filings.
$64.5B in FY2025 with a 5-year CAGR of -5.4%. Ranks 1st among 86 companies in Health Care.
Increased from $59.2B to $64.5B over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +0.7%
- 5-Year CAGR
- -5.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 86This company $64.5B Sector average $6.0B
▼
+983.5% above sector average
Key checks
Key Insights
- 5-year CAGR of -5.4%, indicating a declining trend.
- In FY2025, total debt decreased 3.5% year-over-year.
- Ranks #1 out of 86 companies in the Health Care sector.
- Peak total debt was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $64.5B | -3.5% |
| FY2024 | $66.8B | +12.8% |
| FY2023 | $59.2B | -6.2% |
| FY2022 | $63.1B | -16.9% |
| FY2021 | $76.0B | -10.6% |
| FY2020 | $84.9B | +26.3% |
| FY2019 | $67.2B | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026